News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

Montana State University
|
February 25, 2022

Soon, someone feeling the need for some extra Z’s may benefit from a wearable device that aids the brain in the biochemical cleansing that leaves a person feeling refreshed after a full night of sleep. As part of the first large-scale study on the effectiveness of the new technology, Montana State University researchers will analyze brain scans of participants who wear a prototype of the device, which works by applying precise electrical stimulation to the brain. The project, which involves multiple universities, […]

University of Montana
|
February 25, 2022

University of Montana first-year student Tori Matteson can’t point to a specific event that peaked her interest in becoming a pharmacist – there aren’t any in her family – but her curiosity about medicine started early in her high school years growing up in Butte. When it came time to enroll in college…she said it was “UM all the way.”

Montana company Solo-Dex has entered into an agreement for its proprietary continuous nerve block catheters with InfuSystem, a leading national healthcare service provider.

University of Montana
|
February 23, 2022

As research programs grow at the University of Montana, a team of vaccine scientists are making headway into long-term COVID-19 prevention and clinical trials for an opioid vaccine.

ARTICLES OF INTEREST

National Institutes of Health
|
March 27, 2023

SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. The next deadline is April 5. Omnibus Solicitations. Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These FOAs do not specify a topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations. Specific Funding […]

FDA advisers endorsed the safety and efficacy of GSK’s respiratory syncytial virus (RSV) vaccine in older adults, setting up a final mad dash with Pfizer as both companies eye the regulatory finish line with their promising new vaccines.

Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology  that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.

Doctors have told health services to prepare for a new era of cancer screening after a study found a simple blood test could spot multiple cancer types in patients before they develop clear symptoms.

It’s been 60 years since President Kennedy delivered his iconic moonshot speech, marking a goal for America to launch a man into space to step foot on the moon, and bring him back to Earth. On Sept. 12, President Biden gave a speech at the Kennedy Presidential Library in Boston, outlining the progress on his own self-described moonshot: ending cancer.

NEWSLETTER

Newsletter
|
February 2, 2023

View the Winter 2022 now!

Newsletter
|
November 30, 2022

View the Fall 2022 now!